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Pictographs, ancient surgical tools and fossilised
bodies bare witness to the fact that wound care is one
of the earliest forms of medicine practised by man.
Unfortunately, early scientific knowledge existed
alongside religious and superstitious ideas. In some
societies chronic wounds such as leg ulcers were
viewed as an outward manifestation of evil.
Treatments often involved making the body
uninhabitable to demons, e.g. by beating, starving and
torturing the patient.
As societies became more civilised they began to
study the effects of various medicaments on wound
healing. In China, the colourful Yellow and Red
Emperors compiledthe firstbook ofherbal treatments.
In Egypt, a 100 page encyclopaedia of medicine
(found within the Ebers papyrus) records the fact that
various salves and dressings couldbe made fromresin,
honey, lard and beef. By around 600 BC surgery in
India had advanced to the point that Sasruta was able
to describe rhinoplasty and the cauterisation of
wounds. This was particularly useful as 'nasal
amputations' were a frequent punishment ofthe time.
Unfortunately, wound management remained
something of a hit or miss affair. Those fortunate
enough to be treated by the followers of the great
physician Hippocrates would have had their wounds
bathed in warm sea water and bound in olive leaves -
with a little stretch of the imagination this regime
could be likened to the modem practice ofcleansing a
wound with normal saline and applying a moist, non-
adherent dressing. The less fortunate suffered
immeasurable harm through,
"balsams, astringentgums, ointments andother
idle inventions for mundifying, incarning, or
cicatrizing ofwounds" (Dictionary ofArts and
Sciences, 1815)Y
As we approach the Millennium one would expect
doctors and nurses to have a clear understanding of
modem wound care practices. However, section 1 of
the Oxford Textbook of Surgery (1995), opens with a
quote2 which states that,
'Nowhere is the gap between basic research and
clinical application more glaring than in the
biology ofwound healing'
Despite the plethora of research into modem wound
management many practitioners continue to treat
wounds with products which can harm healing tissues.
For example, it is still common practice to pack cavity
wounds with gauze. Electron micrographs have shown
that newly formed capillary loops can grow through
the weave of the gauze mesh. When the dressing is
removed, the newly-formed granulation tissue can be
literally ripped apart. In addition, fibres from the
gauze are shed into the wound bed and have the
potential to act as a foci for infection. Interestingly,
saline soaks (in the form of 'wet to dry' dressings) are
used as a method of debridement in some areas of
America and the Third World. One can only wonder
why practitioners in the UK continue to use them as a
primary contact layer for a clean granulating wound.
An anonymous surgical treatise dated 1446 was
recently discovered in the British library. Bound
within, is a 9000-word manuscript on ulcers which
showed that medieval leg ulcer management was
systematic and logical. This manuscript highlights the
importance of classifying the ulcer and of using
bandages to treat venous ulcers. It also highlights the
importance ofholistic care and makes great reference
to the importance of treating other illnesses, giving
analgesia (albeit in the form of cannabis and alcohol)
and improving the patients nutritional status. In view
of the fact that many modem day patients with leg
ulcers have not had their ulcers diagnosed and
therefore appropriately treated, it would seem that we
still have a lot to learn from our ancestors.
Most practitioners will be aware that the use of
antiseptics as an aid to modern wound healing is the
subject of heated debate. Antiseptics were developed
in the latter halfofthe 19th Century and the early part
of the 20th Century by Lister, Fleming and others. A
review of the literature of 1915 showed that the
surgeons of the day believed that antiseptics were
responsible for saving the lives of many people,
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particularly the wounded soldiers of the Great War3.
Indeed, whilst lecturing on war wounds, Bowlby,
Surgeon in Ordinary to the King, said,
".... and ifI am told that the antiseptics I have
employed to the skin and to the wound have
played no part, and that sterilised water would
have done as well, Ishould reply thatIknow by
experience that until we diduse antiseptics very
thoroughly we didnotgetthese results, andthat
the wounds which have been treated in the
mannerdescribed have done consistently better
than those ofprevious years. "
Despite this glowing testimony modem research has
questioned the ritualistic use of antiseptic solutions.
For example, a much quoted paper by Leaper and
Simpson4 indicates that hypochlorites, e.g. Eusol
(Edinburgh University Solution of Lime) were
particularly toxic to fibroblasts, granulation tissue and
permanently damaged the micro circulation. They,
therefore, suggested that all topical antiseptics should
be used with caution56. It is interesting to note that
Fleming was very aware of the side effects of
antiseptics. He stated that,
".. It is necessary, in the estimation ofthe value
ofan antiseptic, to study it's effect on the tissue
more than it's effect on the bacteria".
Although some research would appear to support the
fact that antiseptics are cytotoxic, unequivocal,
empirical evidence on the use of the same is not
available. However, most wound care experts feel that
the evidence is strong enough for them to recommend
physiological saline (0.9%) as the cleansing agent of
choice.
Prior to the invention ofthe 'Gamgee' dressing (1880)
most wounds were dressed with oakum - a fibrous
mass ofunpicked old rope. Thomas states7 that this,
"must have represented a significant hazard to
the patient from prior contamination by
chemical, physical and microbiological
agents. "
Although cotton wool was readily available the
greases present in its natural state rendered it virtually
non absorbent. Samson Gamgee discovered that he
could remove the hydrophobic components of cotton
wool through a bleaching process. Gamgee tested the
clinical effectiveness ofhis invention by applying it to
one small wound8.
Nearly 120 years later Gamgee-type dressings are still
used in the treatment oflarge and orheavily exudating
wounds. Although these dressings are relatively cheap
their cost effectiveness can be questioned on two
counts. The first is that they are not an 'ideal' primary
wound contact layer (see Table), i.e they adhere to and
shed fibres into the wound bed and they do not
maintain a moist wound healing environment. The
second is that they readily allow 'strike-through' of
exudate which effectively creates apath fororganisms
to colonise or infect healing tissue.
TABLE
Key Components ofthe Ideal Dressing"
* Maintains a high humidity at the wound -
dressing interface
* Removes excess exudate and toxic components
* Allows gaseous exchange
* Allows no leakage ofexudate
* Maintains wound temperature
* Impermeable to bacteria
* Free from particulate and toxic contaminants
* Does not disintegrate when moist
* Allows trauma-free dressing change
* Comfortable for the patient
During World War I Lumiere developed 'tulle gras'
(paraffin gauze). As paraffin is an excellent carrier for
medicaments, e.g. antibiotics, medicated variations
soon appeared. Common examples include Sofra-
Tulle and Fucidin-Intertulle. Early studies indicated
that medicated tulles could reduce the risk of sepsis
and promote healing. However, later studies began to
highlight serious side effects such as contact
dermatitis and the emergence of resistant strains of
micro-organisms"910.
Although paraffin gauze is sold as a low adherent
primary contact material, most nurses would argue to
thecontrary. Unless changedfrequently Paraffin gauze
dries and become incorporated into the granulating
tissue. It is not uncommon for patients to suffer
considerable pain as the dressing is gently prised from
the wound bed (irrigating the dressing with water or
saline is of limited benefit as paraffin is hydrophobic
in nature). In some instances the pain can be severe
enough to warrant the use of narcotic analgesia or
Entonox11. Ifthe dressing has adhered its removal will
inevitably result in the removal of new granulation or
epithelial tissue. Visible evidence of trauma includes
the characteristic criss-cross pattern which is present
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on the wound bed and bleeding12. In the light of these
problems and the emergence of more sophisticated
wound management products the use of tulle is in
general decline.
The concept of moist wound healing is commonly
attributed to the work of Dr. George Winter in 19622.
Winter's research unequivocally proved that wounds
heal two to three times quicker in a moist
environment. Under dry conditions the bed ofan open
wound rapidly dries out and forms a scab. New
epidermal cells burrow under this scab until they
locate a moist environment, so extending the healing
phase. Once they find a moist environment they will
migrate across the wound. Today a moist environment
can be createdby arapidly expanding array ofmodern
wound care products. These include hydrocolloids,
alginates, hydrogels and hydropolymer foams. The
type of product chosen usually depends on the depth
of tissue damage, the type of tissue in the wound bed





Necrotic tissue in the wound bed will significantly
delay and in some cases prevent healing. Ifthe limb is
viable, the necrotic matter must be removed. Sharp
debridement is the quickest method. However, in
instances where sharp debridement is not appropriate
various topical applications can be effective. These
include hypochlorites, enzymatic agents, hydrogels
and larvae.
Hypochlorites, e.g. Eusol, are non selective. They will
remove viable as well as non viabletissue. Despite this
and the pre stated adverse effects some surgeons find
hypochlorites useful in the preparation of an area for
grafting. However, the Welsh Centre for the Quality
Control ofSurgical Dressings inBridgend'3 calculated
that it would take about 100 ml ofEusol to dissolve 1
gram of slough. In their opinion this can be achieved
more effectively by modern wound care products, e.g.
hydrogels.
Enzymatic products such as streptokinase/
streptodornase act to liquefy slough. However, the
topical application of streptokinase has been shown to
result in a significant production of anti-streptokinase
antibody. The production peaks at one month and then
declines over a six month period. It is suggested that it
may be prudent to avoid the use of topical
streptokinase in patients who are at risk of coronary
artery thrombosis. It is also suggested that if a
thrombolytic agent is required within six months of
administrating topical streptokinase/ streptodornase,
intravenous streptokinase shouldbe withheld infavour
of an alternative thrombolytic agent"4"5.
Hydrogels actively rehydrate devitalised tissue by
donating water to the desiccated matter. The
rehydration process creates a moist environment
which facilitates autolysis. The efficacy of hydrogels
is reduced in the presence of excess exudate. In this
instant it is better to use a product such as an alginate
which will use (absorb) the exudate to produce a gel.
Although the use of larvae (Biotherapy) may seem
radical to some, the use and effectiveness of the same
has been known for hundreds of years. Indeed in the
1st quarter of this century larvae of the common
green-bottle (Lucilia Sericata) was widely used in the
management of infected and necrotic wounds. Their
use simply declined with the advent ofthe widespread
use of antibiotics in the 1940s16. The first therapeutic
use of maggots is credited to J. F. Zacharias, a
Confederate medical officer during the American
Civil War. Zacharias reported that,
"Maggots in a single day would clean a wound much
better than any agents we had at our command" 17,16*
During World War I Baer, an orthopaedic consultant,
had occasion to treat two wounded soldiers who had
been left lying on the battlefield for a week. Baer
found that although the soldiers' compound fractures
and abdominal wounds swarmed with maggots the
wounds were granulating and free from infection.
Later, as a clinical professor of orthopaedic surgery,
Baer decided to use maggots to treat several cases of
intractable osteomyelitis. The wounds healed in six
weeks'8.
The use of larvae became very popular in the 1930's,
so much so that the larvae ofthe green-bottle fly were
produced commercially by Lederle. Many papers
highlighting their therapeutic effectiveness,
particularly in the management of oestomyelitis,
appeared in the medicaljournals'92'2'.
Although the use ofantibiotics resulted in a decline in
the use of larvae, papers reporting the beneficial
effects of myiasis appeared from time to time2223. In
latter years the emergence of antibiotic-resistant
strains of bacteria has lead to a renewed interest in
larvae.
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Larvae are thought to combat wound infection in one
of two ways. The most popular theory is that they
ingest micro-organisms which are then destroyed in
their gut. However, a few of the early papers refer to
the fact that larvae exude a broad spectrum
antibacterial substance known as allantoin2425.
Unfortunately, the clinical significance of allantoin
has not been fully investigated'6.
Sterile larvae, which are approximately 2 mm long,
are introduced into the wound using an aseptic
technique. The larvae produce a powerful mix of
proteolytic enzymes which liquefy necrotic debris.
The liquefied material is then re-absorbed and
digested. Under favourable conditions, larvae rapidly
increase in size, reaching 8 - 10 mmwhenfully grown.
The larvae are removed after a maximum of 3 days.
Thomas'6 states that larvae are a potent therapeutic
tool and must be used with caution. The main
contraindications would appear to be wounds with a
tendency to bleed.
In the past dressing materials were used to clean and
protect wounds, today they are used to enhance wound
healing by creating the ideal environment for the
natural wound healing processes to take place.
Futuristic dressings offer something different.
Through a process known as Tissue Engineering,
dressings containing growth factors, extracellular
matrix proteins (collagen, fibronectin and tenascin)
and human dermal fibroblast cells are being
developed. Some of these dressings actually seed
fibroblasts into non healing wounds. As one would
suspect these dressings are expensive - approximately
£300.00perpiece. However, they can be applied on an
out patient basis and the subsequent saving on a
hospital admission may make them a very cost
effective option.
Ofcourse, in Ireland we do not need 'fancy' dressings
as many people possess 'the cure'! Unfortunately, the
cure can range from a poultice of poteen, cow dung,
lard, grass, and marshmallow to the application of
linen taken from a corpse. The fact that well educated
people with chronic wounds choose to undertake 'the
cure" would indicate that some aspect of modem
practice (or some modem practitioners) is failing to
meet their needs.
Plato stated that,
"the cure ofthe part should not be attempted
without treatment ofthe whole"26
This statement embodies the philosophy ofmany past
and present wound management strategies. In other
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words wound management is more than poultices and
maggots, it means ensuring the physical and
psychological comfort of the patient, treating
underlying disease, ensuring appropriate pain relief
and applying an evidence based wound care product.
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